Holders · period archive

CLDX · Celldex Therapeutics Inc. New

Q2 2024 13F holders

← latest ownership dossier

Ticker: CLDX
Type: Equity
Class: COM NEW
Total reported value ($000, long equity)

Manager	Report date	Value	Shares